CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 3.501
EU - Europa 3.355
AS - Asia 1.551
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 8.421
Nazione #
US - Stati Uniti d'America 3.490
UA - Ucraina 805
CN - Cina 691
TR - Turchia 630
IE - Irlanda 605
GB - Regno Unito 517
SE - Svezia 495
FR - Francia 308
DE - Germania 219
FI - Finlandia 153
IN - India 140
RU - Federazione Russa 118
IT - Italia 108
SG - Singapore 72
CZ - Repubblica Ceca 11
CA - Canada 9
EU - Europa 9
IL - Israele 6
IR - Iran 6
PL - Polonia 5
AU - Australia 3
BE - Belgio 3
VN - Vietnam 3
AT - Austria 2
MX - Messico 2
CL - Cile 1
EG - Egitto 1
IM - Isola di Man 1
JO - Giordania 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
Totale 8.421
Città #
Jacksonville 857
Chandler 740
Dublin 602
Southend 454
Princeton 314
Izmir 310
Nanjing 202
Wilmington 184
Cambridge 143
Dearborn 132
Ashburn 130
Beijing 123
Nanchang 74
Woodbridge 68
Ann Arbor 60
Boardman 57
Shenyang 45
Altamura 40
Singapore 37
New York 36
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 32
Jiaxing 28
Changsha 27
Norwalk 24
Moscow 21
Hangzhou 17
Houston 16
Orange 15
Chieti 14
Falls Church 14
Augusta 13
Jinan 13
Los Angeles 13
San Mateo 13
Helsinki 11
Brno 10
Seattle 9
Changchun 8
Lanzhou 8
Zhengzhou 8
Auburn Hills 7
Leawood 7
Munich 5
Ningbo 5
Pune 5
Toronto 5
Mountain View 4
Perugia 4
Taiyuan 4
Tappahannock 4
Anzola Dell'emilia 3
Brussels 3
Hefei 3
Kraków 3
Ottawa 3
Shanghai 3
Taizhou 3
Walnut 3
Cedar Knolls 2
Chaoyang 2
Dong Ket 2
Fuzhou 2
Hillsborough 2
Kocaeli 2
Mexico City 2
Naples 2
Rome 2
Roseto Degli Abruzzi 2
Secaucus 2
Simi Valley 2
Teramo 2
Tortoreto 2
Wuhan 2
Adelaide 1
Andover 1
Ardabil 1
Bangalore 1
Belgrade 1
Buffalo 1
Cairo 1
Casalbordino 1
Chicago 1
Chongqing 1
Douglas 1
Durham 1
Edinburgh 1
Figline Valdarno 1
Florence 1
Frankfurt am Main 1
Glasgow 1
Haikou 1
Hanoi 1
Karak 1
Lahore 1
Las Vegas 1
London 1
Totale 5.184
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 108
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 100
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 98
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 89
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 86
Amylin inhibits hypothalamic dopamine release. 85
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 85
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 84
Determinants of platelet activation in hypertensives with microalbuminuria. 84
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 84
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 83
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 82
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 82
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 82
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 81
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 81
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 79
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 78
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 76
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 75
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 74
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 74
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 74
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 73
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 72
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 72
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 72
Soluble RAGE in type 2 diabetes: association with oxidative stress. 71
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 70
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 70
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 69
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 69
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 69
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 69
Tachykinin-eicosanoid crosstalk in airway inflammation 68
Increased exhaled 8-isoprostane in childhood asthma. 68
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 68
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 68
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 67
Association between PAI-1 and Oxidative Stress in Android Obesity 66
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 66
Measurement of 8-isoprostane in exhaled breath condensate. 66
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 65
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 65
Determinants of platelet activation in Alzheimer's disease 65
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 64
Insulin resistance as a determinant of platelet activation in obese women 64
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 63
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 63
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 63
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 63
Determinants of platelet activation in hypertensives with microalbuminuria. 63
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 62
Role of Platelet Activation in Dementia 61
Effects of anthracyclines on hypothalamic dopamine release. 61
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 61
Insulin resistance as a determinant of platelet activation in obese women. 61
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 61
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 61
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 60
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 60
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 59
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 59
Platelet activation in obese women: role of inflammation and oxidant stress. 59
Increased thromboxane biosynthesis in essential thrombocythemia 58
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 58
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 58
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 57
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 57
Tachykinin-eicosanoid crosstalk in airway inflammation 57
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 57
Determinants of Platelet Activation in Heart Failure. 57
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 57
Validation of leukotriene B4 measurements in exhaled breath condensate. 56
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 56
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 56
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 56
Exhaled leukotrienes and prostaglandins in COPD. 56
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 56
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 56
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE2 production in cells of the myeloid lineage. 56
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 55
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 55
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 55
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 55
Drugs, prostaglandins, and renal function. 55
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 55
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 54
Identification of 8-isoprostaglandin F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 54
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 54
Soluble CD40L as an indicator of platelet Activation in Heart Failure 54
Determinants of Platelet Activation in Heart Failure. 54
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 53
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 53
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 53
In vivo and in vitro effects of different anesthetics on platelet function. 52
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 52
Insulin resistance and platelet activation in obese women 52
Totale 6.648
Categoria #
all - tutte 29.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.763 587 144 6 80 89 117 187 199 28 143 175 8
2020/2021872 145 6 146 0 91 198 2 7 85 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.931 159 197 126 222 189 447 115 134 233 19 40 50
2023/2024804 63 33 61 22 49 256 216 25 2 7 9 61
2024/2025137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 8.667